2 clinical trials found.
-
An Open-Label Study to Investigate the Safety and Pharmacokinetics of Single Ascending Doses of Antisense Oligonucleotide STK-001 in Children and Adolescents with Dravet Syndrome
The purpose of this study is to see how safe and effective a drug called STK-001 is for people with Dravet syndrome. This is an ...Phase
TRIAL ROLE: Sub Investigator
-
STK-001-DS-501 - An Open-Label Extension Study for Patients with Dravet Syndrome who Previously Participated in Studies of STK 001
The purpose of this research study is to look at a possible new therapy for Dravet syndrome, called STK-001. Dravet syndrome is a severe form ...Phase
TRIAL ROLE: Sub Investigator
